Adrelia Allen

PharmD, Executive Director, Clinical Trial Patient Diversity
Merck

Adrelia Allen is the Head of Clinical Trial Patient Diversity at Merck with more than 25 years of experience in clinical research and clinical operations across multiple therapeutic areas. Adrelia was selected as one of the 2022 PharmaVoice 100 Most Inspiring People in the life sciences..


Related Sessions

View full schedule

2025 REGISTRATION OPENING SOON